Milena Paw1, Dawid Wnuk1, Bogdan Jakieła2, Grażyna Bochenek3, Krzysztof Sładek3, Zbigniew Madeja1, Marta Michalik4. 1. Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-378, Kraków, Poland. 2. Division of Molecular Biology and Clinical Genetics, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland. 3. Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland. 4. Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-378, Kraków, Poland. marta.michalik@uj.edu.pl.
Abstract
BACKGROUND: The asthma-related airway wall remodeling is associated i.a. with a damage of bronchial epithelium and subepithelial fibrosis. Functional interactions between human bronchial epithelial cells and human bronchial fibroblasts are known as the epithelial-mesenchymal trophic unit (EMTU) and are necessary for a proper functioning of lung tissue. However, a high concentration of the transforming growth factor-β1 (TGF-β1) in the asthmatic bronchi drives the structural disintegrity of epithelium with the epithelial-to-mesenchymal transition (EMT) of the bronchial epithelial cells, and of subepithelial fibrosis with the fibroblast-to-myofibroblast transition (FMT) of the bronchial fibroblasts. Since previous reports indicate different intrinsic properties of the human bronchial epithelial cells and human bronchial fibroblasts which affect their EMT/FMT potential beetween cells derived from asthmatic and non-asthmatic patients, cultured separatelly in vitro, we were interested to see whether corresponding effects could be obtained in a co-culture of the bronchial epithelial cells and bronchial fibroblasts. In this study, we investigate the effects of the TGF-β1 on the EMT markers of the bronchial epithelial cells cultured in the air-liquid-interface and effectiveness of FMT in the bronchial fibroblast populations in the EMTU models. RESULTS: Our results show that the asthmatic co-cultures are more sensitive to the TGF-β1 than the non-asthmatic ones, which is associated with a higher potential of the asthmatic bronchial cells for a profibrotic response, analogously to be observed in '2D' cultures. They also indicate a noticeable impact of human bronchial epithelial cells on the TGF-β1-induced FMT, stronger in the asthmatic bronchial fibroblast populations in comparison to the non-asthmatic ones. Moreover, our results suggest the protective effects of fibroblasts on the structure of the TGF-β1-exposed mucociliary differentiated bronchial epithelial cells and their EMT potential. CONCLUSIONS: Our data are the first to demonstrate a protective effect of the human bronchial fibroblasts on the properties of the human bronchial epithelial cells, which suggests that intrinsic properties of not only epithelium but also subepithelial fibroblasts affect a proper condition and function of the EMTU in both normal and asthmatic individuals.
BACKGROUND: The asthma-related airway wall remodeling is associated i.a. with a damage of bronchial epithelium and subepithelial fibrosis. Functional interactions between human bronchial epithelial cells and human bronchial fibroblasts are known as the epithelial-mesenchymal trophic unit (EMTU) and are necessary for a proper functioning of lung tissue. However, a high concentration of the transforming growth factor-β1 (TGF-β1) in the asthmatic bronchi drives the structural disintegrity of epithelium with the epithelial-to-mesenchymal transition (EMT) of the bronchial epithelial cells, and of subepithelial fibrosis with the fibroblast-to-myofibroblast transition (FMT) of the bronchial fibroblasts. Since previous reports indicate different intrinsic properties of the human bronchial epithelial cells and human bronchial fibroblasts which affect their EMT/FMT potential beetween cells derived from asthmatic and non-asthmatic patients, cultured separatelly in vitro, we were interested to see whether corresponding effects could be obtained in a co-culture of the bronchial epithelial cells and bronchial fibroblasts. In this study, we investigate the effects of the TGF-β1 on the EMT markers of the bronchial epithelial cells cultured in the air-liquid-interface and effectiveness of FMT in the bronchial fibroblast populations in the EMTU models. RESULTS: Our results show that the asthmatic co-cultures are more sensitive to the TGF-β1 than the non-asthmatic ones, which is associated with a higher potential of the asthmatic bronchial cells for a profibrotic response, analogously to be observed in '2D' cultures. They also indicate a noticeable impact of human bronchial epithelial cells on the TGF-β1-induced FMT, stronger in the asthmatic bronchial fibroblast populations in comparison to the non-asthmatic ones. Moreover, our results suggest the protective effects of fibroblasts on the structure of the TGF-β1-exposed mucociliary differentiated bronchial epithelial cells and their EMT potential. CONCLUSIONS: Our data are the first to demonstrate a protective effect of the human bronchial fibroblasts on the properties of the human bronchial epithelial cells, which suggests that intrinsic properties of not only epithelium but also subepithelial fibroblasts affect a proper condition and function of the EMTU in both normal and asthmatic individuals.
Entities:
Keywords:
Air-liquid interface; Asthma; Epithelial-mesenchymal trophic unit; Human bronchial (myo)fibroblasts; Human bronchial epithelium; Transforming growth factor-β1
Authors: H Bayram; J L Devalia; O A Khair; M M Abdelaziz; R J Sapsford; M Sagai; R J Davies Journal: J Allergy Clin Immunol Date: 1998-11 Impact factor: 10.793
Authors: Katarzyna Wójcik-Pszczoła; Bogdan Jakieła; Hanna Plutecka; Paulina Koczurkiewicz; Zbigniew Madeja; Marta Michalik; Marek Sanak Journal: Cytokine Date: 2017-09-18 Impact factor: 3.861
Authors: Stephen R Reeves; Tessa Kolstad; Tin-Yu Lien; Molly Elliott; Steven F Ziegler; Thomas N Wight; Jason S Debley Journal: J Allergy Clin Immunol Date: 2014-05-27 Impact factor: 10.793
Authors: Jin-Ah Park; Jae Hun Kim; Dapeng Bi; Jennifer A Mitchel; Nader Taheri Qazvini; Kelan Tantisira; Chan Young Park; Maureen McGill; Sae-Hoon Kim; Bomi Gweon; Jacob Notbohm; Robert Steward; Stephanie Burger; Scott H Randell; Alvin T Kho; Dhananjay T Tambe; Corey Hardin; Stephanie A Shore; Elliot Israel; David A Weitz; Daniel J Tschumperlin; Elizabeth P Henske; Scott T Weiss; M Lisa Manning; James P Butler; Jeffrey M Drazen; Jeffrey J Fredberg Journal: Nat Mater Date: 2015-08-03 Impact factor: 43.841
Authors: Fabio Bucchieri; Alessandro Pitruzzella; Alberto Fucarino; Antonella Marino Gammazza; Celeste Caruso Bavisotto; Vito Marcianò; Massimo Cajozzo; Giorgio Lo Iacono; Roberto Marchese; Giovanni Zummo; Stephen T Holgate; Donna E Davies Journal: Exp Lung Res Date: 2017-04-03 Impact factor: 2.459
Authors: Marta Michalik; Katarzyna Anna Wójcik; Bogdan Jakieła; Katarzyna Szpak; Małgorzata Pierzchalska; Marek Sanak; Zbigniew Madeja; Jarosław Czyż Journal: J Allergy (Cairo) Date: 2012-09-03
Authors: Marta Michalik; Katarzyna Wójcik-Pszczoła; Milena Paw; Dawid Wnuk; Paulina Koczurkiewicz; Marek Sanak; Elżbieta Pękala; Zbigniew Madeja Journal: Cell Mol Life Sci Date: 2018-08-12 Impact factor: 9.261
Authors: Katarzyna Wójcik-Pszczoła; Grażyna Chłoń-Rzepa; Agnieszka Jankowska; Bruno Ferreira; Paulina Koczurkiewicz-Adamczyk; Elżbieta Pękala; Elżbieta Wyska; Krzysztof Pociecha; Reinoud Gosens Journal: Pharmaceuticals (Basel) Date: 2022-03-30